Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

A blinded, randomized, controlled trial of three doses of high-dose insulin in poison-induced cardiogenic shock.

Cole JB, Stellpflug SJ, Ellsworth H, Anderson CP, Adams AB, Engebretsen KM, Holger JS.

Clin Toxicol (Phila). 2013 May;51(4):201-7. doi: 10.3109/15563650.2013.770152. Epub 2013 Mar 26. Erratum in: Clin Toxicol (Phila). 2013 Dec;51(10):1246.

PMID:
23530460
2.

Cardiovascular and metabolic effects of high-dose insulin in a porcine septic shock model.

Holger JS, Dries DJ, Barringer KW, Peake BJ, Flottemesch TJ, Marini JJ.

Acad Emerg Med. 2010 Apr;17(4):429-35. doi: 10.1111/j.1553-2712.2010.00695.x.

3.

Insulin versus vasopressin and epinephrine to treat beta-blocker toxicity.

Holger JS, Engebretsen KM, Fritzlar SJ, Patten LC, Harris CR, Flottemesch TJ.

Clin Toxicol (Phila). 2007 May;45(4):396-401.

PMID:
17486481
4.

High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning.

Engebretsen KM, Kaczmarek KM, Morgan J, Holger JS.

Clin Toxicol (Phila). 2011 Apr;49(4):277-83. doi: 10.3109/15563650.2011.582471. Review.

PMID:
21563902
5.

Premises, premises (poisoning-induced cardiogenic shock and high-dose insulin).

Seger D.

Clin Toxicol (Phila). 2013 May;51(4):199-200. doi: 10.3109/15563650.2013.778996. Epub 2013 Mar 26. No abstract available.

PMID:
23530456
6.

A comparison of vasopressin and glucagon in beta-blocker induced toxicity.

Holger JS, Engebretsen KM, Obetz CL, Kleven TL, Harris CR.

Clin Toxicol (Phila). 2006;44(1):45-51.

PMID:
16496493
7.

High dose insulin in toxic cardiogenic shock.

Holger JS, Engebretsen KM, Marini JJ.

Clin Toxicol (Phila). 2009 Apr;47(4):303-7. doi: 10.1080/15563650802701929.

PMID:
19514876
8.

Insulin-dependent rescue from cardiogenic shock is not mediated by phospholamban phosphorylation.

Ablorh NA, Nitu F, Engebretsen K, Thomas DD, Holger JS.

Clin Toxicol (Phila). 2009 Apr;47(4):296-302. doi: 10.1080/15563650902870269.

9.

High-dose insulin: a consecutive case series in toxin-induced cardiogenic shock.

Holger JS, Stellpflug SJ, Cole JB, Harris CR, Engebretsen KM.

Clin Toxicol (Phila). 2011 Aug;49(7):653-8. doi: 10.3109/15563650.2011.593522. Epub 2011 Aug 8.

PMID:
21819291
10.

Insulin improves survival in a canine model of acute beta-blocker toxicity.

Kerns W 2nd, Schroeder D, Williams C, Tomaszewski C, Raymond R.

Ann Emerg Med. 1997 Jun;29(6):748-57.

PMID:
9174520
11.

High-dose insulin and intravenous lipid emulsion therapy for cardiogenic shock induced by intentional calcium-channel blocker and Beta-blocker overdose: a case series.

Doepker B, Healy W, Cortez E, Adkins EJ.

J Emerg Med. 2014 Apr;46(4):486-90. doi: 10.1016/j.jemermed.2013.08.135. Epub 2014 Feb 13.

PMID:
24530120
12.

The effects of Levosimendan on global haemodynamics in patients with cardiogenic shock.

Rokyta R Jr, Pechman V.

Neuro Endocrinol Lett. 2006 Feb-Apr;27(1-2):121-7.

PMID:
16648778
13.

Differential cardiovascular and neuroendocrine effects of epinine and dopamine in conscious pigs before and after adrenoceptor blockade.

van Woerkens LJ, Boomsma F, Man in 't Veld AJ, Bevers MM, Verdouw PD.

Br J Pharmacol. 1992 Oct;107(2):303-10.

14.

Effects of different insulin infusion rates on heart rate variability in lean and obese subjects.

Paolisso G, Manzella D, Tagliamonte MR, Rizzo MR, Gambardella A, Varricchio M.

Metabolism. 1999 Jun;48(6):755-62.

PMID:
10381151
15.

Insulin improves heart function and metabolism during non-ischemic cardiogenic shock in awake canines.

Kline JA, Raymond RM, Leonova ED, Williams TC, Watts JA.

Cardiovasc Res. 1997 May;34(2):289-98.

PMID:
9205542
16.

Intentional overdose with cardiac arrest treated with intravenous fat emulsion and high-dose insulin.

Stellpflug SJ, Harris CR, Engebretsen KM, Cole JB, Holger JS.

Clin Toxicol (Phila). 2010 Mar;48(3):227-9. doi: 10.3109/15563650903555294.

PMID:
20141425
17.

Metabolic effects of low and high doses of insulin during beta-receptor blockade in dogs.

Reikerås O, Gunnes P, Sørlie D, Ekroth R, Mjøs OD.

Clin Physiol. 1985 Oct;5(5):469-78.

PMID:
2996831
18.

The effects of dobutamine, propranolol and nitroglycerin on an experimental canine model of congestive heart failure.

Kamijo T, Tomaru T, Miwa AY, Nakamura F, Kido H, Sugimoto T, Uchida Y.

Jpn J Pharmacol. 1994 Jul;65(3):223-31.

19.

Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance.

Tsagalou EP, Kanakakis J, Anastasiou-Nana MI, Drakos SG, Ntalianis AS, Malliaras K, Lazaris N, Katsaros F, Nanas JN.

Acute Card Care. 2009;11(2):99-106. doi: 10.1080/17482940902807286.

PMID:
19353405
20.

Supplemental Content

Support Center